It was reported that this subcutaneous implantable cardioverter defibrillator (s-icd) delivered inappropriate shock therapy while the patient was sleeping.Review of the stored episode noted that sensing appeared appropriate.Boston scientific technical services (ts) discussed troubleshooting options.Subsequently, the device exhibited t-wave oversensing resulting in delivery of an additional inappropriate shock.Programming changes were made for optimization.This product remains implanted and in service.No adverse patient effects were reported.
|